Literature DB >> 19608099

Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.

Don Gilden1, Randall J Cohrs, Ravi Mahalingam, Maria A Nagel.   

Abstract

Vasculopathies caused by varicella zoster virus (VZV) are indicative of a productive virus infection in cerebral arteries after either reactivation of VZV (shingles) or primary infection (chickenpox). VZV vasculopathy can cause ischaemic infarction of the brain and spinal cord, as well as aneurysm, subarachnoid and cerebral haemorrhage, carotid dissection, and, rarely, peripheral arterial disease. VZV vasculopathy in immunocompetent or immunocompromised individuals can be unifocal or multifocal with deep-seated and superficial infarctions. Lesions at the grey-white matter junction on brain imaging are a clue to diagnosis. Involvement of both large and small arteries is more common than that of either alone. Most patients have a mononuclear cerebrospinal fluid pleocytosis, often with red blood cells. Cerebrospinal fluid pleocytosis and rash are absent in about a third of cases. Anti-VZV IgG antibody in the cerebrospinal fluid is found more frequently than VZV DNA. In recent years, the number of recognised VZV vasculopathies has grown, and accurate diagnosis is important for the effective treatment of these disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19608099      PMCID: PMC2814602          DOI: 10.1016/S1474-4422(09)70134-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  64 in total

1.  Varicella zoster virus vasculopathy and disseminated encephalomyelitis.

Authors:  Donald H Gilden
Journal:  J Neurol Sci       Date:  2002-03-30       Impact factor: 3.181

2.  Ramsay hunt syndrome followed by multifocal vasculopathy and posterior circulation strokes.

Authors:  Gustavo A Ortiz; Sebastian Koch; Alejandro Forteza; Jose Romano
Journal:  Neurology       Date:  2008-03-25       Impact factor: 9.910

3.  Intracerebral hemorrhage with herpes zoster ophthalmicus.

Authors:  R J Elble
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

4.  Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography.

Authors:  Y Kuroiwa; T Furukawa
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

5.  Chickenpox with delayed contralateral hemiparesis caused by cerebral angiitis.

Authors:  J Kamholz; G Tremblay
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

6.  Disseminated multifocal herpes zoster leukoencephalitis and subcortical hemorrhage in an immunosuppressed child.

Authors:  J M Herrold; J S Hahn
Journal:  J Child Neurol       Date:  1994-01       Impact factor: 1.987

Review 7.  The protean manifestations of varicella-zoster virus vasculopathy.

Authors:  Donald H Gilden; Ravi Mahalingam; Randall J Cohrs; Bette K Kleinschmidt-DeMasters; Bagher Forghani
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 8.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

9.  VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male.

Authors:  Yu Miyazaki; Yuichi Riku; Yoji Goto; Kazuo Mano; Mari Yoshida; Yoshio Hashizume
Journal:  J Neurol Sci       Date:  2008-08-30       Impact factor: 3.181

10.  Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster.

Authors:  B Horten; R W Price; D Jimenez
Journal:  Ann Neurol       Date:  1981-03       Impact factor: 10.422

View more
  140 in total

1.  Spinal cord ischemia: aetiology, clinical syndromes and imaging features.

Authors:  Stefan Weidauer; Michael Nichtweiß; Elke Hattingen; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2014-11-16       Impact factor: 2.804

2.  A virulent vasculopathy.

Authors:  A Molloy; D Forde; C De Gascun; N Fanning; G Wyse; O O'Toole
Journal:  BMJ Case Rep       Date:  2011-03-25

Review 3.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

Review 4.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Multifocal strokes in a 56-year-old man with HIV infection.

Authors:  Ariel Lefkowitz; Wayne L Gold; Leanne K Casaubon; Daniel M Mandell; Jeffrey Craig
Journal:  CMAJ       Date:  2015-05-25       Impact factor: 8.262

6.  Hospital Onset Varicella Central Nervous System Vasculitis in a Patient with HIV Infection.

Authors:  Kristin R V Harrington; Patricia Rhyner; Russell R Kempker
Journal:  AIDS Res Hum Retroviruses       Date:  2019-02-04       Impact factor: 2.205

7.  An Atypical Presentation of Varicella Zoster (VZV) Vasculopathy.

Authors:  Zafer Keser; Gerson Suarez-Cedeno; Ram K Saha; Quynh Huong V Pham; Amanda L Jagolino; Tzu-Ching Wu
Journal:  J Vasc Interv Neurol       Date:  2018-06

8.  Clinical benefits of routine varicella vaccination for adults.

Authors:  Cinzia Germinario; Maria Serena Gallone; Maria Giovanna Cappelli; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.

Authors:  Daniel Sacchetti; Aydah Alawadhi; Mustafa Albakour; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2014-04-28

Review 10.  [Juvenile stroke - what is important?]

Authors:  M Fischer; B Eckert; J Röther
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.